Turning Point Therapeutics

YTD

ALL

Why Robinhood?

You can watch TPTX and buy or sell other stocks, ETFs, and their options commission-free!

About TPTX

Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor.

CEO

Sandra Ramos-Alves

CEOSandra Ramos-Alves

Employees

—

Employees—

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2013

Founded2013

Employees

—

Employees—

TPTX Key Statistics

Market cap

3.78B

Market cap3.78B

Price-Earnings ratio

-11.01

Price-Earnings ratio-11.01

Dividend yield

—

Dividend yield—

Average volume

1.17M

Average volume1.17M

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$82.20

52 Week high$82.20

52 Week low

$23.77

52 Week low$23.77

People also own

Based on the portfolios of people who own TPTX. This list is generated using Robinhood data, and it’s not a recommendation.

Virgin Galactic Holdings

NVIDIA